» Articles » PMID: 32416226

Amygdalar Nuclei and Hippocampal Subfields on MRI: Test-retest Reliability of Automated Volumetry Across Different MRI Sites and Vendors

Abstract

Background: The amygdala and the hippocampus are two limbic structures that play a critical role in cognition and behavior, however their manual segmentation and that of their smaller nuclei/subfields in multicenter datasets is time consuming and difficult due to the low contrast of standard MRI. Here, we assessed the reliability of the automated segmentation of amygdalar nuclei and hippocampal subfields across sites and vendors using FreeSurfer in two independent cohorts of older and younger healthy adults.

Methods: Sixty-five healthy older (cohort 1) and 68 younger subjects (cohort 2), from the PharmaCog and CoRR consortia, underwent repeated 3D-T1 MRI (interval 1-90 days). Segmentation was performed using FreeSurfer v6.0. Reliability was assessed using volume reproducibility error (ε) and spatial overlapping coefficient (DICE) between test and retest session.

Results: Significant MRI site and vendor effects (p ​< ​.05) were found in a few subfields/nuclei for the ε, while extensive effects were found for the DICE score of most subfields/nuclei. Reliability was strongly influenced by volume, as ε correlated negatively and DICE correlated positively with volume size of structures (absolute value of Spearman's r correlations >0.43, p ​< ​1.39E-36). In particular, volumes larger than 200 ​mm (for amygdalar nuclei) and 300 ​mm (for hippocampal subfields, except for molecular layer) had the best test-retest reproducibility (ε ​< ​5% and DICE ​> ​0.80).

Conclusion: Our results support the use of volumetric measures of larger amygdalar nuclei and hippocampal subfields in multisite MRI studies. These measures could be useful for disease tracking and assessment of efficacy in drug trials.

Citing Articles

Electroconvulsive therapy-specific volume changes in nuclei of the amygdala and their relationship to long-term anxiety improvement in depression.

Ishikawa Y, Oishi N, Kyuragi Y, Hatakoshi M, Hirano J, Noda T Mol Psychiatry. 2024; .

PMID: 39681629 DOI: 10.1038/s41380-024-02874-1.


Subsegmentation of the hippocampus in subgroups of migraine with aura patients: advanced structural neuroimaging study.

Petrusic I, Radovic M, Dakovic M, Radojicic A, Coppola G J Headache Pain. 2024; 25(1):182.

PMID: 39420262 PMC: 11484179. DOI: 10.1186/s10194-024-01888-y.


Association of concussion history with psychiatric symptoms, limbic system structure, and kynurenine pathway metabolites in healthy, collegiate-aged athletes.

Meier T, Savitz J, Espana L, Goeckner B, Teague T, van der Horn H Brain Behav Immun. 2024; 123:619-630.

PMID: 39414174 PMC: 11624060. DOI: 10.1016/j.bbi.2024.10.015.


Longitudinal changes in brain-derived neurotrophic factor (BDNF) but not cytokines contribute to hippocampal recovery in anorexia nervosa above increases in body mass index.

Keeler J, Bahnsen K, Wronski M, Bernardoni F, Tam F, Arold D Psychol Med. 2024; 54(9):2242-2253.

PMID: 38450444 PMC: 11413355. DOI: 10.1017/S0033291724000394.


Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers.

Evans J, Graves M, Nugent A, Zarate Jr C Sci Rep. 2024; 14(1):4538.

PMID: 38402253 PMC: 10894199. DOI: 10.1038/s41598-024-54370-9.